Trial intelligence / Profile preview

EVEROTAC: Everolimus PK in Kidney Transplant

NCT00325325Phase 2Unknown

Sponsor
Ramón y Cajal University Hospital
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of everolimus in kidney transplant rejection, sponsored by Ramón y Cajal University Hospital. Status: unknown.

02

Drugs

everolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00325325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00325325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call